H

Hyundai Bioscience Co Ltd
KOSDAQ:048410

Watchlist Manager
Hyundai Bioscience Co Ltd
KOSDAQ:048410
Watchlist
Price: 14 670 KRW 1.24% Market Closed
Market Cap: 584.1B KRW
Have any thoughts about
Hyundai Bioscience Co Ltd?
Write Note

Gross Margin
Hyundai Bioscience Co Ltd

46.4%
Current
42%
Average
31.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.4%
=
Gross Profit
4.3B
/
Revenue
9.2B

Gross Margin Across Competitors

Country KR
Market Cap 584.1B KRW
Gross Margin
46%
Country FR
Market Cap 177.9B EUR
Gross Margin
74%
Country UK
Market Cap 118B GBP
Gross Margin
0%
Country IN
Market Cap 5.8T INR
Gross Margin
52%
Country UK
Market Cap 34.5B GBP
Gross Margin
62%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 27.2B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.3T INR
Gross Margin
56%
Country IN
Market Cap 935.5B INR
Gross Margin
49%
Country US
Market Cap 10.1B USD
Gross Margin
35%
No Stocks Found

Hyundai Bioscience Co Ltd
Glance View

Market Cap
584.1B KRW
Industry
Consumer products

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Intrinsic Value
501.94 KRW
Overvaluation 97%
Intrinsic Value
Price
H

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
46.4%
=
Gross Profit
4.3B
/
Revenue
9.2B
What is the Gross Margin of Hyundai Bioscience Co Ltd?

Based on Hyundai Bioscience Co Ltd's most recent financial statements, the company has Gross Margin of 46.4%.